Periprocedural heparin use in acute ischemic stroke endovascular therapy: the TREVO 2 trial.

@article{Winningham2018PeriproceduralHU,
  title={Periprocedural heparin use in acute ischemic stroke endovascular therapy: the TREVO 2 trial.},
  author={Melanie J Winningham and D C Haussen and R G Nogueira and David S. Liebeskind and Wade S. Smith and Helmi L. Lutsep and T G Jovin and Bin Xiang and Fadi Nahab},
  journal={Journal of neurointerventional surgery},
  year={2018},
  volume={10 7},
  pages={
          611-614
        }
}
BACKGROUND The use of periprocedural heparin has previously been reported to be safe and potentially beneficial during thrombectomy with older generation devices. We aimed to evaluate the safety and clinical outcomes of heparin use in the stent retriever era. METHODS A post hoc analysis of the TREVO 2 trial was performed comparing baseline characteristics and clinical outcomes between patients who received (HEP+) and those who did not receive periprocedural heparin (HEP-) while undergoing… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 6 times. VIEW TWEETS